0001104659-24-027574.txt : 20240226 0001104659-24-027574.hdr.sgml : 20240226 20240226170119 ACCESSION NUMBER: 0001104659-24-027574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240222 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hudson Frederick M. CENTRAL INDEX KEY: 0001438462 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 24679964 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm247055-11_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-22 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001438462 Hudson Frederick M. C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 1 0 0 0 0 Common Stock 33231 D Director Stock Option (Right to Buy) 27.94 2024-02-22 4 A 0 8252 0 A 2034-02-22 Common Stock 8252 8252 D Restricted Stock Units 2024-02-22 4 A 0 5369 0 A Common Stock 5369 5369 D The option vests on February 22, 2025. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025. /s/ Timothy C. Dec, as attorney-in-fact 2024-02-26